Rapid Micro Biosystems (RPID) Cash from Investing Activities (QoQ) (2020 - 2026)
Rapid Micro Biosystems (RPID) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Rapid Micro Biosystems | 80.98 Mn | 61.21 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.90% |
| Mar 31, 2026 | 121.15% |
| Dec 31, 2025 | 140.56% |
| Sep 30, 2025 | -202.56% |
| Jun 30, 2025 | -12.52% |
| Mar 31, 2025 | 119.64% |
| Dec 31, 2024 | 174.38% |
| Sep 30, 2024 | -126.34% |
| Jun 30, 2024 | 83.63% |
| Mar 31, 2024 | 35.04% |
| Dec 31, 2023 | 109.99% |
| Sep 30, 2023 | -64.62% |
| Jun 30, 2023 | -3.17% |
| Mar 31, 2023 | 8.67% |
| Dec 31, 2022 | 243.27% |
| Sep 30, 2022 | -503.71% |
| Jun 30, 2022 | 102.22% |
| Mar 31, 2022 | -267.91% |
| Dec 31, 2021 | -5,794.99% |
| Sep 30, 2021 | -110.25% |